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ABSTRACT
Previous meta-analytic results showed beneficial effects of meditation
interventions for cortisol levels. In the present meta-analysis we tested
whether effects are larger for those who might be in need of such stress
reduction programs due to a risk for elevated cortisol levels as compared
to no-risk samples. We included RCTs that measured change in cortisol
levels. Based on 10 studies using blood samples meditation interventions
had a significant, medium effect from pre-to post-test compared to the
control group. Upon closer inspection, this effect was only present for
at-risk samples, that is, patients with a somatic illness. In the 21 studies
using saliva samples the effect was small and not significant, but there
was a marginally significant effect for groups living in stressful life
situations. This pattern may suggest that that meditation interventions are
most beneficial for at-risk populations. These interventions might provide
people with strategies of stress management that can contribute to well-
being. Preliminary results suggest that benefits of meditation interventions
might not fade with time.
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Cortisol is a stress hormone that is released by the activity of the hypothalamic–pituitary–adrenal
(HPA) axis. In addition to a circadian rhythm – after an increase around waking it has a steady
decrease during the day – it shows elevated concentration in reaction to stress. In case of chronic
stress, cortisol shows high concentrations after awakening (Schulz et al., 1998). Higher perceived
levels of stress are related to elevated daily cortisol secretion, which in turn is associated with a
wide array of health complaints (Lovell et al., 2011). Chronic stress can have a negative effect on
the immune and cardiovascular systems and some processes of the metabolism (McEwen, 2004).
There are several mental disorders (e.g., depression or anxiety disorders) and somatic illnesses (Bar-
ičević et al., 2006; Chiodini et al., 2007) or life situations (Chida & Steptoe, 2009) that are characterized
by elevated cortisol levels. For instance, elevated hair cortisol levels were measured in depression
(Dettenborn et al., 2012) and patients with an anxiety disorder show higher cortisol levels in hair
(Steudte et al., 2011) and saliva samples (Mantella et al., 2008). Regarding somatic illnesses, type II
diabetes is associated with elevated blood serum cortisol (Chiodini et al., 2007), while Tsilchorozidou
et al. (2003) showed higher daily cortisol production from urine cortisol metabolites in polycystic
ovarium syndrome (PCOS) patients. It is known that stressful life situations (e.g., low socioeconomic
status) are associated with higher salivary cortisol levels (Cohen et al., 2006). Thus, taking into
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consideration the health risks and the number of conditions that are linked to elevated cortisol levels,
investigating the efficacy of interventions that might help reducing elevated cortisol levels is of high
importance. Furthermore, it is important to assess whether benefits are sustained over time (Slopen
et al., 2014).
Meditation is a widely spreading stress reduction technique. In fact, in a previous meta-analysis
Goyal et al. (2014) found that mindfulness meditation has moderate beneficial effects on symptoms
of anxiety (d = 0.38) and depression (d = 0.30), but no convincing evidence on stress in clinical popu-
lations. Meditation, however, is not a clearly defined concept and it has several different schools.
Mindfulness is one of the most widespread approaches. The goal of mindfulness meditation is to
focus on the sensations and feelings of the present moment and pay attention non-judgmentally
(Kabat-Zinn & Hanh, 2009). Meditation is often used in combination with other practices. For instance,
Integrative Body-Mind Training (IMBT) uses mindfulness training elements and also body relaxation
and mental imagery (Tang, 2011). Mindfulness-Based Stress Reduction (MBSR) and Mindfulness-
Based Cognitive Therapy (MBCT) combine mindfulness meditation practices with elements of cogni-
tive behavioral therapy or some other psychoeducational elements (Fjorback et al., 2011). The most
commonly used components in mindfulness-based programs are breath awareness, psycho-edu-
cation and group discussions (Zenner et al., 2014).
Five categories of meditation techniques are mentioned by Simkin and Black (2014). During
focused attention trainings (FA) meditators are concentrating on explicit objects to avoid the mind
wander. The widely used mindfulness-based programs like MBSR and MBCT belong here. The aim
of open monitoring (OM) techniques is not to concentrating on explicit objects, rather the prac-
titioner is trying to be a monitoring state. Meditative techniques in this category are Sahaja type med-
itations. The third category is transcendental meditation (TM). In this technique, instead of focusing
on something or being aware of the moment, the meditator repeats a mantra. The goal of this action
is to subside the thoughts and mental processes. Mind–body approaches (M-B) can involve com-
ponents from the previous three techniques. And finally, body–mind programs (B-M) use movement
series thus these are body-centered but can also incorporate elements from the first three types.
Body–mind programs include movements like dance therapy or yoga, etc.
In a meta-analysis MBSR compared to wait-list controls was found to be effective in reducing self-
reported stress (Cohen’s d for MBSR group was 0.74, while it was – 0.21 for the control group),
however, results are not conclusive whether these benefits remain more than 3 months later (Chiesa
& Serretti, 2009). In a systematic review, Fjorback et al. (2011) found that only the minority of the
studies include follow-up assessments after more than a year. Moreover, self-reported assessment of
stress is more prone to bias, while objective biomarkers such as cortisol levels might be more suitable
for a firm test of the effects of meditation on stress (Matousek et al., 2010). Sanada et al. (2016) con-
ducted a meta-analysis of the available randomized controlled trials (RCTs) of mindfulness-based pro-
grams on salivary cortisol levels in non-clinical adult populations and revealed a significant, moderate-
sized benefit of almost half a standard deviation (g = .41, p = .025). Pascoe et al. (2017) synthesized the
results of the RCTs regarding the effects of any types ofmeditation compared to an active control group
on blood cortisol data and also found a significant, medium effect (Z =−2.92, p < .01). However, there is
a call for investigating the long-term effects of meditation (Chiesa & Serretti, 2009; Fjorback et al., 2011).
According to Creswell and Lindsay (2014) mindfulness has positive effects on health outcomes via
improving stress management (mindfulness stress buffering hypothesis). The authors proposed that
mindfulness affects both top-down and bottom-up stress processes in the brain including increased
activation in regulatory areas like the prefrontal cortex and decreased stress reactivity in, for instance,
the amygdala. Based on the stress buffering account, Creswell and Lindsay (2014) predicted that
mindfulness-based interventions should have the largest effect for at-risk populations: highly stressed
people or populations with diseases that are susceptible to stress such as mental disorders and
somatic illnesses like inflammatory diseases or diabetes.
Based on these previous considerations, the main aim of the present study was to assess whether
meditation is more effective in samples who are in most need of stress reduction: samples with
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elevated cortisol levels, that is, clinical samples and participants in stressful life situations as compared
to healthy subjects with supposedly lower cortisol levels. Secondly, we investigated whether the
benefits of meditation are sustained over time by focusing on the latest follow-up assessments.
Additionally, we extended the previous results in several ways: (i) we included all kinds of meditative
interventions as we expected similar benefits of mindfulness-based as other schools of meditation
such as zen or transcendental meditation, (ii) we also included any cortisol sampling procedure,
not only saliva or blood, but also urine samples because there is a high correlation between cortisol
concentration measured from blood and saliva samples (Obayashi, 2013), and urine (Contreras et al.,
1986). Besides the aforementioned, hair cortisol is also included because it reflects the changes in
cortisol secretion as well (Wright et al., 2015), (iii) we did not restrict our search to active control con-
ditions, and finally, (iv) we did not restrict our search according to participants’ age or clinical status as
we aimed to test whether meditative interventions have different efficacy at different ages and in
samples who are at risk for elevated cortisol levels.
In line with previous results (Pascoe et al., 2017; Sanada et al., 2016), it was hypothesized that med-
itation interventions decrease cortisol levels because of their stress-reducing effects (Goyal et al.,
2014). However, while Goyal et al. (2014) found an effect of mindfulness-based programs (e.g.,
MBSR, MBCT, Zen meditation, etc.), they did not find one of mantra meditation (e.g., Transcendental
meditation). The evidence in the included studies regarding mantra meditation was low or insuffi-
cient. On the other hand, in a literature review Walton et al. (2002) state that transcendental medita-
tion does reduce stress. Furthermore, we expected a larger effect for samples that are at risk for
elevated cortisol levels (based on the mindfulness stress buffering account of Creswell and Lindsay
2014). Finally, regarding the long-term effects of these programs, we expected smaller effects with
more and more time after the end of the intervention. For instance, Hsiao et al. (2016) found a
larger effect right after the intervention as compared to follow-up measures at 3, 6 and 12 months.
Methods
Operational definitions
Meditation in the present study was defined as a contemplative activity during which subjects focus
their attention on the object of the meditation instead of letting their minds wonder, regardless of
what the object of meditation is: for instance, breathing, sensations in the body, a mantra, sounds
or one’s thoughts. Accordingly, all schools of meditative practices (e.g., mindfulness, transcendental
or zen meditation) were included (similar to Goyal et al., 2014; Pascoe et al., 2017).
We aimed to assess the effect specifically for subjects who are at a risk for elevated cortisol levels.
In the primary studies the effect of meditation was assessed regarding a variety of at-risk samples, for
example, participants with a somatic illness (e.g., cancer, Bränström et al., 2013), polycystic ovary syn-
drome (Stefanaki et al., 2015), cardiovascular disease (Robert McComb et al., 2004), type 2 diabetes
(Jung et al., 2015), or samples with a mental illness (e.g., depression (Gex-Fabry et al., 2012), or
post-traumatic stress disorder (Kim et al., 2013)) in addition to clinically indicated samples such as
participants showing depressive symptoms (Prakhinkit et al., 2014). Furthermore, participants
living in stressful life circumstances were also considered as at-risk groups (e.g., cancer survivors
(Carlson et al., 2013), dementia caregivers (Oken et al., 2010), or low socioeconomic status (Sibinga
et al., 2013)). See Table 1 for an overview of the risk factors in the primary studies in addition to refer-
ences confirming that these conditions are associated with elevated cortisol levels.
Search strategy
We conducted a systematic search in the databases of Web of Science (Core collection), EBSCO (Psy-
chInfo, PsychArticles, MEDLINE) and PubMed for journal articles and in the ProQuest database for dis-
sertations and theses with a detailed search string (Appendix 1) up to November 15, 2018, to locate all
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randomized controlled trials that used meditation as an intervention and cortisol measures before
and after the intervention to calculate the change in cortisol levels as an outcome (see the
PRISMA diagram in Figure 1). All searching and screening procedures were done independently by
Table 1. Risk factors for elevated cortisol levels in the primary studies.
Risk factor Reference
Cancer diagnosis Andersen et al., 1989
Chronic pain (e.g., fibromyalgia) Van Uum et al., 2008
Depression Dettenborn et al., 2012
Generalized anxiety disorder Mantella et al., 2008
Glaucoma Schwartz et al., 1987
History of cardiovascular disease Manenschijn et al., 2013
Inflammatory gastrointestinal diseases
(e.g., colitis ulcerosa, Cohn’s disease)
Baričević et al., 2006
Low socioeconomic status (Low-SES) Cohen et al., 2006
Polycystic ovary syndrome (PCOS) Tsilchorozidou et al., 2003
Posttraumatic stress disorder (PTSD) Steudte et al., 2011
Stressful life situations (Caregiving of patients with dementia can lead
to depression over time Wright et al., 1999)
Chida & Steptoe, 2009
Type 2 diabetes Chiodini et al., 2007
Figure 1. PRISMA Flow diagram.
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the first author and a research assistant. As a secondary search, the reference lists of the included
articles and other review studies were checked to find all relevant articles by the coders of the study.
Inclusion criteria
(1) The intervention condition had to include meditation as the main component of the intervention
(e.g., the intervention was a meditation-based program like MBSR or MBCR). The study was
excluded if meditation was only a small part of the program (e.g., Dialectical Behavior Therapy
is a type of cognitive–behavioral program for treating mental disorders that also uses mindful-
ness elements during acceptance procedures (Dimeff & Linehan, 2001), however, the basis of
the program is not mindfulness.)
(2) There had to be a passive or an active control condition without meditation to which the medita-
tion condition could be contrasted.
(3) The study had to have a randomized controlled design.
(4) There had to be an outcome measure regarding participants’ cortisol levels on pre- and post-test/
follow-up: either a single measure, the average of multiple measure(s), the diurnal mean or the
area under curve respect to the ground (AUCg) during the day. Alternatively, the first sample
taken before a stress test was also included as long as it was taken at approximately the same
time of the day on the post-test/follow-up as on the pre-test.
(5) The study had to be written in English.
We had no restrictions regarding the age or clinical status of the participants in the primary studies.
Coding procedure
The following informations were coded: (a) bibliographic information, (b) sample characteristics (e.g.,
at-risk for elevated cortisol levels or not), (c) characteristics of the meditation intervention (e.g., length
of the intervention), (d) characteristics of the control condition (e.g., active or passive), (e) cortisol
sampling, and (f) effect size information (sample sizes, and means and standard deviations of cortisol
measures in the meditation and the control groups on pre- and post-test/follow-up), (g) the number
of days between the end of the intervention and the post-test/follow-up cortisol sampling, (h) type of
meditation, (i) intervention components, (j) risk of bias. If the necessary information to calculate the
effect size (for example, if a study reported only diurnal slope but not the means of cortisol levels at
each time point (e.g., Bränström et al., 2013)) or to estimate the number of days between the end of
the intervention and the cortisol sampling was not available, we contacted the authors by e-mail.
In order to test the long-term effects of meditation intervention programs, we conducted a meta-
regression analysis in which we used the elapsed time after the intervention until the cortisol
measurement to test whether the effects of the interventions fade with time. In case of hair
samples (because it is a retrospective analysis with about one cm of hair sample reflecting the
total cortisol production from the last month) we calculated the ‘mean’ of the sampling time (for
example in case of a hair sample from one month after the intervention we coded 15 days). If the
hair sample was collected within one month from the end of the program (e.g., Nery et al., 2018;
Younge et al., 2015) we excluded the study because the sample thus contained cortisol from the
time of the intervention and cannot be regarded as a post-test.
To test the effect of the length of the intervention we coded the whole length, but we made an
exception for one study (Vandana et al., 2011) in which subjects partook in an eight-month-long
intervention. Measures were taken after 48 hours, two months and eight months from the start of
the program. In this case, instead of using the measure taken at the end of the intervention (after
8 months), we chose to include the intermittent measure taken two months after the beginning
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of the intervention because two months of intervention was more similar in length to the interven-
tions used in the other studies.
Additionally, we coded risk of bias in the included randomized controlled trials using the Cochrane
Collaboration’s risk of bias tool 2.0 (Sterne et al., 2019). This criteria tool measures with specific ques-
tions on five domains such as the randomization process, assignment to intervention, missingness of
data, the measurement and selective reporting. Based on the five domains’ results, coders decide the
overall risk level of the study.
All included studies were coded by two independent coders. The coders were the first author, the
research assistant who was involved in the searching and screening process along with other univer-
sity students. Disagreements were settled in discussion, and if the coders could not make a decision,
the first and the last authors were included in the discussion. The Krippendorff’s alpha values of inter-
rater reliability (Krippendorff, 1980) were calculated with the KALPHA macro for SPSS (Hayes & Krip-
pendorff, 2007). Based on these values inter-rater reliability was always acceptable, ranging from 0.99
(total time of the intervention) to 1.00 (gender distribution).
Meta-analytic procedure
In this meta-analysis we synthetized the evidence regarding the effects of meditation on change in
cortisol levels from pre-test to post-test/follow-up assessment. Additionally, we used a meta-
regression analysis to test the effect of time between the end of the intervention and the cortisol
assessment to investigate whether effects fade with time. The dependent variable in the present
study was the standardized mean difference between the meditation and the control group in the
change in cortisol from pre- to post-test/follow-up. We utilized the standardized mean difference
as an effect size because different sampling strategies were used in the primary studies: a single
measurement (Jung et al., 2015), the diurnal mean calculated from more measures (Cash et al.,
2015) or the area under the curve respect to the ground (AUCg). If different cortisol indices were
reported in a study, we preferred the AUCg measure first, followed by the mean of multiple measures
instead of a single measurement. We used the effect size estimate Hedges’ g, which is similar to
Cohen’s d but corrects for small sample sizes (Borenstein et al., 2009). Effect sizes are considered
low around 0.20, medium around 0.50 and large around 0.80 (Cohen, 1988) as an agreement in
behavioral sciences (Stoové & Andersen, 2003). Only one study (Malarkey et al., 2013) reported the
correlation between the pre- and post-test scores so we standardized the effect sizes by the post-
test standard deviations. Data were entered and analyzed in the Comprehensive Meta-Analysis Soft-
ware 3.3 (Borenstein et al., 2014). If more post-test/follow-up measurements were available in a study,
we included all of those and the program calculated the mean of the effect sizes before including the
study in the grand average over the different studies. However, for testing the sustained effects in a
meta-regression, we only included the results of the cortisol sample that was taken at the latest from
the end of the intervention program. In case results were reported for more than one control con-
dition in a study we included both contrasts. For instance, Prakhinkit et al. (2014) used a sedentary
control and a traditional walking exercise as control conditions. Again, the software takes the
average of the two effect sizes in one study as these are not independent from each other before
calculating a grand average.
Positive effect size indicates the advantage of the meditation intervention for cortisol levels as
compared to the control condition, that is, either a larger decrease or a smaller increase from pre-
to post-test. Effect sizes were inspected for outliers (exceeding a standardized residual of +/−3.29).
As the primary studies employed different samples, meditation interventions, control conditions
and cortisol sampling approaches, average effect sizes and corresponding 95% confidence intervals
were calculated based on the random-effects model, which allows for between-study variances (Bor-
enstein et al., 2009).
Publication bias means that due to having more difficulty publishing non-significant results, sig-
nificant findings might be overrepresented in meta-analyses (Borenstein et al., 2009). We used the
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funnel plot method (Egger et al., 1997) to assess the possibility of publication bias, which plots the
inverse of the standard errors (precision) against the effect sizes of the individual studies. An asym-
metrical plot suggests that studies with non-significant results might be missing. In case of asym-
metry, Duval and Tweedie’s trim and fill method (Duval & Tweedie, 2000) can be applied to adjust
the average effect size. Rosenthal’s fail-safe N method (Rosenthal, 1979) estimates the confidence
of the results by calculating the number of studies with non-significant results that would be
needed to turn the average effect non-significant. As a rule of thumb, the average effect size is
robust if the number is larger than 5k +10 (where k is the number of the studies included).
Additionally, we used the weight function model (Vevea & Hedges, 1995) that gives a corrected
effect size as a result of the adjusted model. This adjusted estimate corrects the effect with pre-
specified weights of p-value intervals. Heterogeneity of the average effect size was calculated by
the Q-statistics and I2. Significant heterogeneity means that the variability between effect sizes
cannot be attributed to sampling error alone (Borenstein et al., 2009). When the Q-value shows
a heterogenous effect it is sensible to conduct moderator analyses in order to explain the variance.
The I2 (Higgins & Thompson, 2002) shows what part of the total variation is caused by the hetero-
geneity between studies in percentage. As a rule of thumb of interpreting I2 values under 40% is
considered low, between 40–60% moderate, and 60–90% substantial (Schünemann, 2013). Modera-
tor analyses were conducted to (1) test the difference between at-risk and no-risk samples, (2) test
the effects of time (the number of days between the end of the intervention and the cortisol
sampling on post-test/follow-up), and (3) to check potential sources of bias such as differences
in the interventions, the control conditions and the cortisol sampling procedure. In case of categ-
orical variables, we applied subgroup analyses, while for numerical variables regression analyses
were conducted. Statistical power calculations were based on recommendations of Hedges and
Pigott (2004). If there was not sufficient statistical power, only descriptive results were reported
regarding the moderator variables (see Kassai et al., 2019 for a similar procedure). For more
details on the statistical power analyses see Appendix 2. Each of the above-mentioned analyses
was performed separately for each sample source.
Results
Effect of meditation on blood cortisol
We synthetized the results of 10 studies including data of 395 participants’ using blood samples. For
the characteristics of the studies see Table 2. Four of these studies utilized a focused attention (FA)
type meditation program and were based on mindfulness, three of them used transcendental med-
itation, two applied body–mind and one mind–body program. In all the studies one blood sample
was taken. Only one study did not provide more information (Jung et al., 2015), while nine studies
(90%) sampled cortisol in the morning. Five mentioned that sampling was done after fasting. The
classic fail-safe N method showed that 67 non-significant studies would turn the average effect
non-significant. Thus, according to Rosenthal’s criterion, the average effect was robust. The funnel
plot was symmetrical so there were no signs of publication bias. Risk of bias in the included
studies was ‘some concerns’ in case of eight studies, while in case of one study it was low and in
another it was high (see Table 2 and Appendix 3). Meditation interventions had a medium effect
on the change in cortisol levels (g = 0.62, k = 10, SE = 0.21, 95% CI = [0.22, 1.02], p = .003). The effect
was heterogeneous (Q (9) = 28.99, p = .001), I2 = 68.95, 95% CI = [0, 92]. The weight function model
produced a bigger effect estimate (g = 1.20, 95% CI = [0.47, 1.91]) and the likelihood of this model
was −1.66 and for the original model it was 0.70. The likelihood ratio test was significant (p = .03) indi-
cating that the adjusted model could be better. Additionally, we tested the overall effect excluding
one study at a high risk for bias (Robert McComb et al., 2004). The effect remained medium-sized and
significant (g = 0.62, k = 9, SE = 0.23, 95% CI = [0.18, 1.07], p = .006). This effect was also hetero-
geneous (Q (7) = 28.98, p < .001), I2 = 72.40, 95% CI = [3, 94].
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There was also a significant medium-sized effect for at-risk samples and a large but non-significant
effect for no-risk samples. Without the high-risk bias study, there was a similar, marginally significant
effect for at-risk samples (g = 0.50, k = 7, SE = 0.26, 95% CI = [−0.004, 1.007], p = .052) and it was het-
erogeneous (Q (6) = 21.06, p = .002), I2 = 71.51, 95% CI = [0, 93].
We investigated the efficacy of meditation interventions for different at-risk samples. Three
studies included participants with a mental problem and showed no effects of the interventions.
Five studies included participants with a somatic illness. In these studies the effect was large
and significant. Furthermore, we checked the effect of methodological differences between the
primary studies. To test the effect of the type of control group we excluded three studies (Jung
et al., 2015; Prakhinkit et al., 2014; Vandana et al., 2011) that used both an active and a passive
control condition. In contrast to active control groups, there was a large, marginally significant
effect of meditation intervention, while compared to passive controls, the effect size was
medium-sized and non-significant. We did not have enough statistical power to compare these
subgroups. One study did not report information about the time of sampling (Jung et al., 2015),
while the others took samples before noon (for more details and the results of subgroup analyses
see Table 3 and Figure 2 and 3).
We had sufficient statistical power to run meta-regression analyses (Table 4). Intervention duration had
a significant positive effect on the effect size after excluding one outlier (MacLean et al., 1997) suggesting
that longer meditation interventions had larger effects on participants’ blood cortisol levels. It seems that
interventions longer than 1200 minutes seem to be most effective (see Figure 4). The other interesting
finding is that these programs are more effective for men (see Figure 5). We were unable to test the
effect of the elapsed time after the intervention until the post-test cortisol sampling because only three
studies reported on this information. There was no effect of age (see Table 4).
Effect of meditation on salivary cortisol
There was one outlying study (Stefanaki et al., 2015) based on standardized residuals. After exclud-
ing that study, we synthesized the results of 21 trials including data of 1163 participants. For the
characteristics of the studies see Table 2. Nineteen of these studies utilized a meditation
program based on mindfulness and used focused attention (FA) type meditation, while one
used mind–body (M-B) (Hsiao et al., 2016) and the other study a body–mind (B-M) intervention
(Fan et al., 2013). Only five studies (24%) took saliva samples on more days: one of them
sampled one per day, while two sampled four and another two on five occasions during the
Table 3. Effects of meditation interventions on change of blood cortisol in the different subgroup moderator analyses for
methodological differences in the primary studies.
Moderator g k n SE
95% CI
p
Q statistic I2 statistic




No risk 1.08 2 118 0.66 −0.22 2.37 .104 6.92 1 .009 86% 0% 99%
At-risk 0.51 8 277 0.23 0.06 0.96 .026 21.06 7 .004 67% 0% 93%
Type of problem in case of at-risk samples
Mental −0.02 3 100 0.34 −0.69 0.64 .945 4.96 2 .08 60% 0% 97%
Somatic 0.87 5 177 0.19 0.49 1.24 <.001 5.18 4 .26 23% 0% 87%
Stressful life situation - - - - - - - - - - - - -
Control condition
Active 0.85 4 110 0.44 −0.002 1.70 .051 13.94 3 .003 78.48 0% 97%
Passive 0.40 3 100 0.59 −0.76 1.56 .500 14.39 2 .001 86.10 0% 98%
Sampling time
A.M. 0.63 9 339 0.23 0.17 1.08 .007 28.97 8 <.001 72.39 0% 93%
P.M. - - - - - - - - - - - - -
Note: g = Hedges’ g; CI = confidence interval, LL = lower limit; UL = upper limit.
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day. Sixteen studies (76%) sampled on only one day and half of them sampled on three or more
occasions per day, in seven studies samples were taken on only one occasion per day, while one
study sampled twice on the sampling day. From all the included studies, only three synchronized
all sampling times to waking times. The classic fail-safe N method showed that 11 non-significant
studies would turn the average effect non-significant. Thus, according to Rosenthal’s criterion, the
average effect was not robust. The Duval and Tweedie’s trim and fill method showed eight trimmed
studies and the adjusted effect size was g = −0.10 and non-significant (95% CI = [−0.33; −0.13]). Risk
Figure 2. Forest plot for all included studies.
Figure 3. Forest plot for subgroups in at-risk categories.
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of bias analyses in these studies indicated some concerns and only one study’s risk was low (see
Table 2 and Appendix 3). Meditation had a small and marginally significant effect on change in cor-
tisol levels in salivary samples (g = 0.18, k = 21, SE = 0.11, 95% CI = [−0.04, 0.40], p = .102). The effect
was heterogeneous (Q (20) = 56.77, p < .001, I2 = 64.77, 95% CI = [11, 86]). Estimating the effect with
the weight function model resulted in a negative effect (g = −0.10, 95% CI = [−0.28, 0.08]) and the
likelihood of this model was −1.73 and −2.50 for the original model. The likelihood ratio test was
non-significant (p = .21) indicating that the original model is as good as the adjusted one. After
excluding the two studies that reported on the results of participants under 18 years (Schonert-
Reichl et al., 2015; Sibinga et al., 2013) the effect was similar in size and marginally significant (g
= 0.20, k = 19, SE = 0.10, 95% CI = [−0.002, 0.398], p = .052). Again, this was a heterogeneous
effect (Q (18) = 37.02, p = .005) I2 = 51.38, 95% CI = [0, 83].
Furthermore, we assessed the moderator of the samples’ risk status. For both at-risk and no-risk
samples the effect was small and not significant. We had insufficient statistical power to contrast
the above mentioned average effect sizes. We also investigated the efficacy of meditation interven-
tions for different at-risk samples. For the results of subgroup analyses see Table 5 and Figure 3. Three
studies reported on participants with a diagnosis or symptoms of a mental illness and three on
somatic problems. On average, there was no significant effect of meditation either for the samples
Figure 4. Effect of the length of the intervention in blood samples.
Table 4. Results of meta-regression analyses for methodological differences in the primary studies that used blood cortisol
sampling.
Regression Coefficient k SE
95%CI
pLL UL
Gender distribution 0.0114 10 0.0049 0.0018 0.0209 .020
Mean age −0.0022 10 0.0133 −0.0284 0.0239 .867
Total intervention time 0.0010 9 0.0004 0.0003 0.0018 .009
Elapsed time after intervention – – – – – –
Note: CI = confidence interval, LL = lower limit; UL = upper limit.
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with a mental disorder or in the studies including participants with somatic issues. In the six studies
that tested samples in stressful life situation a marginally significant, medium effect appeared. The
statistical power was not enough to compare the above-mentioned categories. One study with a
sample at a risk for elevated cortisol levels including pregnant women (Zhang & Emory, 2015)
could not be categorized into the above-mentioned categories.
To check the methodological differences between the primary studies we, again, ran subgroup ana-
lyses (see Table 5). For testing the effect of the type of control group, we excluded those studies that
Figure 5. Effect of gender distribution in blood samples.
Table 5. The effect in change of salivary cortisol. Results of subgroup moderator analyses for methodological differences in the
primary studies.
95% CI Q statistic I2 statistic
95% CI
Moderator g k n SE LL UL p Q df(Q) p I2 LL UL
Risk status
No risk 0.32 8 354 0.25 −0.17 0.82 .200 31.46 7 <.001 78% 13% 94%
At-risk 0.12 13 809 0.12 −0.11 0.35 .297 25.31 12 .013 53% 0% 87%
Type of problem in case of at-
risk samples
Mental −0.16 3 106 0.24 −0.64 0.31 .505 2.91 2 .233 31% 0% 94%
Somatic −0.05 3 306 0.16 −0.36 0.26 .765 3.40 2 .184 41% 0% 94%
Stressful life situation 0.40 6 371 0.22 −0.02 0.83 .062 13.75 5 .017 64% 0% 93%
Control condition
Active 0.22 8 614 0.23 −0.22 0.66 .323 38.17 7 <.001 82% 33% 94%
Passive 0.13 11 477 0.12 −0.09 0.36 .246 14.64 10 .146 32% 0% 83%
Sampling time
A.M. 0.40 4 153 0.17 0.06 0.73 .020 2.15 3 .541 0% 0% 74%
P.M. 0.74 3 104 0.33 0.10 1.39 .024 4.14 2 .126 52% 0% 96%
A.M. and P.M. 0.01 12 804 0.14 −0.27 0.29 .951 33.37 11 <.001 67% 0% 90%
Sampling procedure
One sample/day 0.39 8 320 0.14 0.12 0.66 .005 9.57 7 .215 27% 0% 85%
More samples 0.04 13 843 0.14 −0.23 0.32 .756 36.09 12 .001 67% 0% 90%
Note: g = Hedges’ g; CI = confidence interval, LL = lower limit; UL = upper limit.
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used both an active and a passive control condition (Jensen et al., 2011; Oken et al., 2010). There were
no significant effects of meditation compared either to active or passive control groups and we had
insufficient statistical power to contrast them. In case of those four studies that reported the time of
sampling, studies in which they collected samples before noon showed a small and significant
effect, and in those three studies that sampled in the afternoon the effect was large and also significant.
Those 12 studies that sampled both AM and PM showed an effect that was near to zero and non-sig-
nificant (see Table 5). There was no sufficient statistical power for contrasting. Two studies did not
report this information (Turan et al., 2015; Van Dam, 2013). Additionally, we tested the effect of the
number of cortisol samples that were collected in the primary studies. In case of the 13 studies that
collected multiple samples, 12 of them collected them both AM and PM (the same group as mentioned
above), while in one study (Jensen et al., 2011) they collected samples before noon. There was no sig-
nificant effect in those studies that collected multiple samples. In those studies that collected only one
sample during a day (three sampled AM, three sampled PM and two did not give any information)
(Turan et al., 2015; Van Dam, 2013) the effect was medium-sized and significant (see Table 5). There
was not enough statistical power to contrast them.
We had enough statistical power for all the meta-regression analyses (Table 6). There were no
effects of gender distribution, the age of the participants or the total time of the intervention. In
case of the elapsed time after the intervention we excluded one study (Hsiao et al., 2016) because
it was an outlier in this regard (the latest sampling was after one year). The effect was non-significant
(see Table 6 and Figure 6).
Comparison of results from blood and saliva samples
As the results show, a significant main effect of meditation interventions was found in the studies that
utilized blood samples. More specifically, these interventions had a large effect on samples with a
somatic illness. In contrast, studies assessing saliva cortisol showed no significant main effect of med-
itation interventions except for the subset of studies that sampled people living in stressful life situ-
ations. Thus, a plausible explanation for the differential main effects of meditation interventions on
blood and saliva cortisol is that 80% of the studies focusing on blood cortisol included at-risk samples
and, more specifically, half of the studies included participants with a somatic illness (for whom a
large effect was found). On the other hand, only 62% of the studies focusing on saliva samples
included at-risk participants, more specifically, 14% of the studies recruited participants with a
somatic illness and 29% included samples living in stressful life situations (for whom a moderate-
sized effect was found). In sum, the overall large effect found on blood samples might be explained
by the fact that the proportion of studies with at-risk samples (and more specifically, patients with a
somatic illness) was larger for these studies as compared to trials utilizing saliva samples to assess
cortisol levels.
Another possible explanation is that 90% of the blood samples were taken before noon, in which
studies the effect was medium-sized and significant. In contrast, studies that took saliva samples
before noon also showed a medium-sized and significant effect. However, half of these studies
included at-risk samples. If we look at those studies that collected saliva samples both before and
afternoon, there was no effect. Nine of these studies (75%) focused on at-risk samples. A puzzling
Table 6. Results of meta-regression analyses for methodological differences in the primary studies that use salivary cortisol.
Regression Coefficient k SE
95%CI
pLL UL
Gender distribution 0.0024 21 0.0042 −0.0059 0.0107 0.572
Mean age 0.0023 21 0.0081 −0.0136 0.0182 0.775
Total intervention time 0.0000 19 0.0002 −0.0004 0.0004 0.981
Elapsed time after intervention 0.0001 15 0.0023 −0.0043 0.0045 0.962
Note: CI = confidence interval, LL =lower limit; UL = upper limit.
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finding is that saliva samples taken in the afternoon showed a large and significant effect. In sum,
although no clear pattern emerges, the timing of cortisol sampling could have an effect on the
results.
Effect of meditation on hair cortisol
Only two included studies reported results based on hair cortisol. Mindfulness-based and focused
attention (FA) interventions were used in both studies. The average effect size of the two studies
including a total of 223 participants showed no effect (g =−0.01, k = 2, SE = 0.13, 95% CI = [−0.27,
0.25], p = .94), which was a homogeneous result (Q (1) = 0.43, p = .510, I2 = 0.00). Gotink et al.
(2017) reported results of participants with no risk (structural heart disease) and found a null effect
(g =−0.04, k = 1, SE = 0.14, 95% CI = [−0.31, 0.24], p = .79) compared to a passive control condition.
The overall risk of bias in this study indicated some concerns. Goldberg et al. (2014) reported
results of at-risk participants as they were in the middle of smoking cessation. In this study there
was a small and non-significant effect of the intervention (g = 0.28, k = 1, SE = 0.45, 95% CI =
[−0.61, 1.16], p = .54) compared to an active control condition. There were some concerns regarding
the risk of bias in this study.
Effect of meditation on urine cortisol
One study assessed the effects of a meditation intervention on urine cortisol of 29 participants (Jedel
et al., 2014). In this study there was a non-significant, medium-sized negative effect (g =−0.41, k = 1,
SE = 0.36, 95% CI = [−0.13, 0.31], p = .27) of the Mindfulness-Based Stress Reduction program com-
pared to an active control condition in an at-risk sample of inactive ulcerative colitis patients. The
risk of bias showed some concerns in this study.
Discussion
The present meta-analysis provides a synthesis of all available evidence regarding the efficacy of
meditation interventions on the change in participants’ cortisol levels in different sampling
Figure 6. Effect of the elapsed time after the intervention in saliva samples.
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sources. Effects were tested not only on the short-, but also on the long-term. Additionally, we
assessed whether participants at a risk for elevated cortisol levels (e.g., due to mental and somatic
illnesses or a stressful life situation) benefit more from these interventions as compared to no-risk
samples. We extended previous results by an exhaustive review of the available evidence: we
included studies with any sources of cortisol sampling (saliva, blood, urine or hair), any types of med-
itation interventions, any control conditions (active or passive) and any samples of participants. Still, it
should be noted that most of the included studies utilized a meditation program based on mindful-
ness. Risk of bias was also evaluated.
In 10 randomized controlled trials including data of 395 participants, there was a significant,
medium-sized effect of meditation interventions on changes in cortisol levels in blood samples (g
= 0.62), however, there were some concerns about the risk of bias in the included studies. The pub-
lication bias indicators did not suggest any problems so the effect seems to be robust. This finding is
in line with the result of Pascoe et al. (2017) who found a medium-sized effect of meditation inter-
ventions on blood cortisol.
There was a significant, medium-sized benefit of meditation interventions for at-risk samples and a
non-significant but large effect for no-risk participants when considering blood samples. More specifi-
cally, meditation interventions showed a large, significant effect on cortisol for samples with a
somatic illness and no effect for samples with mental problems. Thus, partially in line with our expec-
tations and the mindfulness stress buffering account of Creswell and Lindsay (2014) who predicted
more benefits of mindfulness interventions for at-risk samples (people experiencing a large amount
of stress or having an illness that is susceptible to stress), upon closer inspection we only found a sig-
nificant effect for samples with a somatic illness. It should be noted that there were only two no-risk
samples in the studies focusing on blood cortisol and we did not have enough statistical power to
statistically contrast effects for the different samples. Thus, these results should be considered
preliminary.
When assessing results on salivary cortisol, there was no main effect of meditation interventions or
any effects for at-risk or no-risk samples either. However, there was a moderate-sized benefit of these
programs for samples living in stressful life situations such as low-income family members, dementia
caregivers, cancer survivors or cancer patients. Additionally, when we focused on adult participants
only, there was a marginally significant, small effect for no-risk samples. It should be noted that we
found signs of a possible publication bias and the average effect size was not robust. Moreover, the
risk of bias in the primary studies was categorized as ‘some concerns’ with one exception, thus the
results should be regarded cautiously. The reason for this categorization in most cases was a lack of a
statistical analysis plan reported.
In sum, we found differential main effects of meditation interventions on blood and saliva
samples, however, we suspect that it is due to the larger ratio of studies with at-risk samples and,
more specifically, patients with a somatic illness in the studies focusing on blood samples. This is
also conceivable as access to blood samples is more likely in studies including hospitalized
samples as compared to studies utilizing saliva samples. Upon closer inspection, both sets of
studies seem to show, in line with our hypothesis, that meditation interventions are especially ben-
eficial for samples at a risk for elevated cortisol levels.
A puzzling finding is that meditation interventions showed no effects, based on the available three
studies on blood cortisol and three studies on salivary cortisol for participants with a diagnosis or
symptoms of a mental disorder. This contrasts previous results showing the benefits of meditation
for symptoms of depression and anxiety (Goyal et al., 2014). Further research is warranted.
In contrast to previous reviews, we intended to conduct meta-regression analyses to test the sus-
tained effect of meditation interventions on follow-up assessments. We could only test this variable
on saliva samples. Surprisingly, when focusing on the results of the cortisol sampling furthest in time
from the end of the intervention, we did not find any significant effect of the time between the end of
the intervention and the sampling on the effect size on salivary cortisol. This is a very preliminary
result, but it seems to suggest that effects do not disappear with time. We have no information
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regarding whether participants sustained a meditation practice after the intervention, but it is also
plausible that a few weeks long meditation program could provide participants with strategies of
stress management that are used on the long-run, even without a lasting meditation practice. At
the same time, we would like to emphasize that only a very limited number of studies provided infor-
mation on more than three-month follow-up assessment. Further studies including repeated assess-
ments over longer periods of time are needed.
An interesting finding of the present study was the significant effect of the length of the interven-
tions on the effect size in case of blood samples suggesting that longer meditation programs were
more effective in stress reduction. This result has important practical implications. Interventions
longer than 20 hours seem to be most effective as shown in Figure 6.
Finally, in contrast with Sanada et al. (2016) results regarding salivary cortisol, a puzzling finding of
the present study is a marginally significant effect of gender ratio in the studies assessing blood cor-
tisol. We found that meditation interventions might be more effective for men.
Recommendations for future research
Based on our results and the state of the available scientific evidence, further research is clearly
needed. As our results show, the available information regarding the effect of meditation programs
on cortisol levels of people with mental problems is very limited. Further RCTs should focus on homo-
geneous samples with diagnosed mental disorders in order to get a clear picture on the effectiveness
of these techniques for such populations. Although Goyal et al. (2014) found that mindfulness has
beneficial effects on symptoms of anxiety and depression, it is not clear yet whether this effect
can also be confirmed by cortisol results. Furthermore, with substantially more studies focusing on
homogeneous samples with mental disorders future meta-analyses will be able to invesitage for
which disorders meditation interventions might be beneficial. In contrast, it seems that meditation
can be beneficial in case of somatic problems (based on blood cortisol results) and for people in
stressful life situations (based on salivary cortisol results). However, these categories were still very
heterogeneous. Further RCTs with a variety of somatic disorders and stressful life situations will
enable more specific suggestions.
Another gap in the literature is that most of the evidence come from adult samples. In fact, we only
found two studies assessing the effects of a meditation intervention on children’s cortisol levels
(Schonert-Reichl et al., 2015; Sibinga et al., 2013). It is not clear yet if these techniques could be
effective in reducing children’s cortisol levels because the available results are contradictory.
Further RCTs should be conducted with children. Measurement of cortisol levels from saliva, hair
and urine are non-invasive procedures that can be easily implemented with children.
An interesting result of the present study is that meditation interventions might be more effective
for males than for females. Further studies should directly contrast the efficacy of programs for the
two genders and investigate the possible reasons for this difference.
Finally, the field should be more rigorous regarding the design of RCTs and limit the moderate
level risk of bias found in the present meta-analysis. While most of the included studies performed
well on the first four domains of the Cochrane Collaboration’s risk of bias tool 2.0 (Sterne et al.,
2019), almost none of them mentioned that there was a pre-specified analysis plan. Further
researches should pre-specify and report a detailed statistical analysis plan.
Recommendations for clinical practice
In contrast to Goyal et al. (2014) findings that symptoms of anxiety and depression can be effectively
decreased with mindfulness, we could not confirm this with results on cortisol in the present meta-
analysis. However, we found that meditative programs can be used for people in life situations where
with a risk for elevated cortisol levels such as caregivers of dementia patients, or in case of people
with somatic illnesses (e.g., colitis ulcerosa or Cohn’s disease). Additionally, longer programs were
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found more effective and it is recommended that meditative interventions should last at least 20
hours in order to reach the desired effect (e.g., Jung et al., 2015 or Frisvold, 2009) (see Figure 4).
Recommendations for future meta-analyses
In our meta-analysis we extended previous review results by investigating whether meditation-based
programs are equally effective for different populations. With substantially more available primary
studies, future meta-analyses will be able to further specify the efficacy of such interventions for
different at-risk groups such as people diagnosed with an anxiety disorder.
Limitations
There was a small number of randomized controlled trials of meditation interventions that provided
information on changes in cortisol levels that we could include and they used different sample
sources (e.g., blood, saliva, urine and hair samples) or sampling schedules (one or more sampling
occasion per day, sampling on one or more consecutive days). Unfortunately, only two studies reported
on hair and one reported on urine cortisol results, thus this part of the present meta-analysis remains
descriptive and preliminary. Accordingly, statistical power in the present meta-analysis was low for all
subgroup analyses, however, we had sufficient power to conduct themeta-regression analyses. Further-
more,most studies used ameditation intervention based onmindfulness and thus other schools ofmed-
itation are highly underrepresented. Additionally, interventions in the primary studieswere complex and
not described in details making it difficult to determine what exactly happened during the sessions.
We assessed whether effects were larger for samples at a risk for elevated cortisol levels. We
reported results for samples with a somatic illness, participants with a diagnosis or symptoms of a
mental disorder and subjects living in stressful life situations – conditions that have been shown
to be associated with higher cortisol levels. Still, these are highly heterogeneous groups. Without
more studies to be included in a meta-analysis like the present one, however, we cannot make
more fine-grained analyses. It is important to point out that although we only included randomized
controlled trials, the risk of bias in these studies was mostly categorized as ‘some concerns’.
Finally, the measurement of cortisol also varied substantially in the primary studies. In case of saliva
samples, studies tended to report on less reliable cortisol estimates such as a single sample or a daily
average as opposed to indicators such as the AUCg. Furthermore, the risk status of the sample and the
source of cortisol sampling seem to be confounded thus it is difficult to make definite conclusions.
Conclusion
Meditation interventions were shown to have a significant medium effect on changing cortisol levels
assessed from blood samples, which is in line with the conclusions of a previous meta-analysis. More
specifically, significant effects were found for samples at a risk for elevated cortisol levels such as
patients with a somatic illness and people living in stressful life situations. Preliminary results seem
to show that the beneficial effects of meditation programs might not fade with time. Finally,
longer meditation programs were found to be more effective.
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Appendices
Appendix 1
The search string utilized in title and abstract to allocate all relevant publications:
(cortisol OR adrenocortic* OR glucocortic* OR hydrocortisone) AND (meditat* OR mindful*) AND (experiment* OR
“randomized controlled” OR “randomized control” OR “randomised control” OR RCT).
Appendix 2
Table A1. Results of statistical power analyses of subgroup analyses.
Comparison Statistical power (Blood cortisol) Statistical power (Salivary cortisol)
Risk status
No Risk – At risk – 18%
At risk
Mental – Somatic 10% 14%
Mental – Stressful life situation – 12%
Somatic – Stressful life situation – 16%
Control condition
Active – Passive 6% 17%
Sampling time
AM- PM – 10%
AM- Both – 20%
PM- Both – 18%
Sampling procedure
One sample/day – More samples – 25%
Table A2. Results of statistical power analyses of meta regression analyses.
Regression Statistical power (Blood cortisol) Statistical power (Salivary cortisol)
Gender distribution 100% 100%
Mean age 100% 100%
Total intervention time 100% 100%
Elapsed time after intervention – 100%
Appendix 3
Table A3. Risk of bias in the included studies in each domain.
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